Firocoxib 189954-96-9 Anti-inflammatory NSAID
Kev Them Nyiaj:T / T, L / C
Khoom Keeb Kwm:Tuam Tshoj
Shipping Chaw nres nkoj:Beijing / Shanghai / Hangzhou
Kev txiav txim (MOQ):25kg ua
Lub Sijhawm Lead:3 hnub ua haujlwm
Muaj peev xwm ntau lawm:80kg / hli
Kev cia khoom:Khaws rau hauv qhov chaw txias, qhuav, chav sov.
Cov khoom siv pob:nruas
Pob loj:25kg / nruas
Cov ntaub ntawv kev nyab xeeb:Tsis yog khoom txaus ntshai
Taw qhia
Felrocoxib yog ib qho tseem ceeb uas tsis yog-steroidal anti-inflammatory veterinary tshuaj, thiab nws cov nyhuv feem ntau yog los ntawm kev xaiv inhibiting cov synthesis ntawm prostaglandins mediated los ntawm cyclooxygenase-2 (COX-2) los thaiv cov txiv laum huab xeeb plaub.Alkenoic acid hloov mus rau hauv prostaglandins, uas nyob rau hauv lem muaj antipyretic, analgesic thiab anti-inflammatory zog.Piv nrog rau lwm cov tshuaj uas tsis yog-steroidal anti-inflammatory veterinary tshuaj, filocoxib tuaj yeem ua tau zoo thiab xaiv inhibit COX-2, thiab tuaj yeem nqus tau sai los ntawm lub cev, uas muaj cov txiaj ntsig tseem ceeb ntawm kev kho mob osteoarthritis.
Specification (hauv tsev qauv)
| Yam khoom | Specification |
| Qhov tshwm sim | Dawb mus rau dawb crystalline hmoov |
| Kev txheeb xyuas | UV, IR, HPLC |
| Poob rau ziab | ≤ 0.5% |
| Residue ntawm ignition | ≤0.1% |
| Cov hlau hnyav | ≤10ppm |
| Cov khoom muaj feem xyuam | P0Z1 ≤0.5% |
| M1Z1 ≤0.5% | |
| P0Z6 ≤0.5% | |
| P0Z7 ≤0.5% | |
| M2Z4 ≤ 0.5% | |
| Lwm yam impurity ≤0.2% | |
| Tag nrho impurities ≤2.0% | |
| Cov kuab tshuaj residual | Ethanol ≤5000ppm |
| Ethyl acetate ≤5000ppm | |
| Triethylamine ≤5000ppm | |
| Acetonitrile ≤410ppm | |
| Dichloromethane ≤600ppm | |
| Assay | 98.0% ~ 102.0% (xws li qhuav hauv paus) |
